The NMDA receptor complex as a therapeutic target in epilepsy: a review
- PMID: 22056342
- DOI: 10.1016/j.yebeh.2011.07.024
The NMDA receptor complex as a therapeutic target in epilepsy: a review
Abstract
A substantial amount of research has shown that N-methyl-D-aspartate receptors (NMDARs) may play a key role in the pathophysiology of several neurological diseases, including epilepsy. Animal models of epilepsy and clinical studies demonstrate that NMDAR activity and expression can be altered in association with epilepsy and particularly in some specific seizure types. NMDAR antagonists have been shown to have antiepileptic effects in both clinical and preclinical studies. There is some evidence that conventional antiepileptic drugs may also affect NMDAR function. In this review, we describe the evidence for the involvement of NMDARs in the pathophysiology of epilepsy and provide an overview of NMDAR antagonists that have been investigated in clinical trials and animal models of epilepsy.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
The chemical biology of clinically tolerated NMDA receptor antagonists.J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x. J Neurochem. 2006. PMID: 16805772 Review.
-
AMPA receptors in epilepsy and as targets for antiepileptic drugs.Adv Neurol. 1999;79:947-63. Adv Neurol. 1999. PMID: 10514878 Review.
-
LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.Br J Pharmacol. 1998 Nov;125(6):1258-66. doi: 10.1038/sj.bjp.0702172. Br J Pharmacol. 1998. PMID: 9863655 Free PMC article.
-
NMDA receptor antagonists and pain: ketamine.Vet Clin North Am Equine Pract. 2010 Dec;26(3):565-78. doi: 10.1016/j.cveq.2010.07.009. Vet Clin North Am Equine Pract. 2010. PMID: 21056300 Review.
-
N-methyl-D-aspartate receptor antagonists for migraine: a potential therapeutic approach.Med Hypotheses. 2009 May;72(5):603-5. doi: 10.1016/j.mehy.2008.11.037. Epub 2009 Jan 24. Med Hypotheses. 2009. PMID: 19168292
Cited by
-
Sinapinic acid as a potential therapeutic agent for epilepsy through targeting NMDA receptors and nitrite level.Sci Rep. 2024 Oct 22;14(1):24941. doi: 10.1038/s41598-024-77099-x. Sci Rep. 2024. PMID: 39438606 Free PMC article.
-
Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus.Neuroscience. 2013 Sep 17;248:602-19. doi: 10.1016/j.neuroscience.2013.06.029. Epub 2013 Jun 27. Neuroscience. 2013. PMID: 23811393 Free PMC article.
-
Decreased Glucose Utilization Contributes to Memory Impairment in Patients with Glufosinate Ammonium Intoxication.J Clin Med. 2020 Apr 23;9(4):1213. doi: 10.3390/jcm9041213. J Clin Med. 2020. PMID: 32340163 Free PMC article.
-
Ketamine and its combinations with valproate and carbamazepine are ineffective against convulsions induced by atropine treatment and food intake in fasted mice.Iran J Basic Med Sci. 2019 Mar;22(3):310-314. doi: 10.22038/ijbms.2019.33890.8062. Iran J Basic Med Sci. 2019. PMID: 31156793 Free PMC article.
-
Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.Int J Mol Sci. 2017 Jul 30;18(8):1617. doi: 10.3390/ijms18081617. Int J Mol Sci. 2017. PMID: 28758944 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
